Case Report


Low-dose systemic thrombolysis in patient with recent major abdominal surgery and high-risk pulmonary embolism: Case report and narrative review

,  ,  

1 Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy

2 Department of Emergency Medicine, ASST Santi Paolo e Carlo, San Carlo Borromeo Hospital, University of Milano – Statale, Milan, Italy

3 Unità Operativa Complessa Pronto Soccorso, 118 e Medicina d’Urgenza, Dipartimento Chirurgico e Grandi Traumi, Maurizio Bufalini Hospital, Cesena (FC), Italy

Address correspondence to:

Michele Domenico Spampinato

Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, St. Anna Hospital, Via A. Moro 8, Cona, Ferrara,

Italy

Message to Corresponding Author


Article ID: 100057Z09MS2021

doi: 10.5348/100057Z09MS2021CR

Access full text article on other devices

Access PDF of article on other devices

How to cite this article

Spampinato MD, Frezza F, Nigra SG. Low-dose systemic thrombolysis in patient with recent major abdominal surgery and high-risk pulmonary embolism: Case report and narrative review. J Case Rep Images Med 2021;7:100057Z09MS2021.

ABSTRACT


Introduction: Systemic thrombolysis is the treatment of choice for hemodynamically unstable patients with acute pulmonary embolism (PE) while for the intermediate-high risk ones the possibility of severe bleeding seems to outweigh the benefits. Surgical or percutaneous therapy is an option in case of contraindication/failure of fibrinolysis but they are not available in every hospital.

Case Report: An 85-year-old woman arrived at the Emergency Department for rapid onset dyspnea, thoracic pain with hypotension, tachycardia, and hypoxia. A computed tomography pulmonary angiography revealed acute PE of the main branches of the pulmonary right and left arteries. Due to hemodynamic instability and a history of recent intestinal resection surgery (25 days before), a continuous infusion of low-dose thrombolysis regimen with 50 mg rt-PA in 2 hours was started. After 30 minutes of rt-PA infusion, all vital signs were improved and at the end of rt-PA infusion. Point of care ultrasound (POCUS) revealed a reduced size of right ventricle with a decrease in right/left ventricle ratio. Hospital stay and a follow-up at two weeks revealed no complication due to the fibrinolytic administration or anticoagulant therapy.

Conclusion: Anticoagulation is still the cornerstone therapy for patients with PE, but there’s a lack of trials on reperfusion strategy. Moreover, different guidelines give different short-term risk classifications, indication, and dosage of thrombolytic drugs and absolute and relative contraindications to systemic thrombolysis. This case report shows the potential benefit of low-dose rt-PA in patients with relative contraindications to thrombolysis and presenting with vital signs compatible with hemodynamic instability.

Keywords: Emergency medicine, Point of care systems, Pulmonary embolism, Systemic thrombolysis

SUPPORTING INFORMATION


Author Contributions

Michele Domenico Spampinato - Substantial contributions to conception and design, Drafting the article, Final approval of the version to be published

Francesco Frezza - Substantial contributions to conception and design, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published

Stefano Geniere Nigra - Substantial contributions to conception and design, Revising it critically for important intellectual content, Final approval of the version to be published

Guaranter of Submission

The corresponding author is the guarantor of submission.

Source of Support

None

Consent Statement

Written informed consent was obtained from the patient for publication of this article.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Conflict of Interest

Authors declare no conflict of interest.

Copyright

© 2021 Michele Domenico Spampinato et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.